Virtual twins could predict liver and heart risks in fatty liver patients
NCT ID NCT07430501
First seen Feb 26, 2026 · Last updated Jun 16, 2026 · Updated 16 times
Summary
This observational study aims to create detailed computer models, or 'virtual twins,' of patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Researchers will use data from over 7,700 participants to better understand how the disease progresses and to predict heart problems. The goal is to improve personalized care, but this study does not test any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vall d´Hebron Institute de Recerca (VHIR)
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.